© 2004 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine
WARM UP
Warm up
Genedicine
| The first 150 words of the full text of this article appear below. |
Continuing my occasional forays into gene technology, I was interested to see that regulatory authorities in China have licensed a gene therapy based treatment. This is the first time anywhere in the world that such a treatment has been authorized.
Although the therapy relates to head and neck squamous cell carcinoma (a huge problem in southern China) the technology is relatively straightforward. The company, SiBiono GeneTech, uses an adenovirus as the vector to insert a gene designed to limit cancer cell growth. The results of trials have been published in the peer reviewed Chinese Medical Journal and show this technique to be dramatically effective compared with conventional radiotherapy. The beauty of the technique is that the virus does not integrate into the cell genome (thereby minimising the risk of leukaemia) but rather confines itself to the malignant cell line. The simplicity of the technique is echoed in the
Relevant Article
- The Promethean fire
- P McCrory
Br. J. Sports Med. 2004 38: 1.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
